How long does the pneumonia vaccine last?

Written by Li Jian Wu
Pulmonology
Updated on February 16, 2025
00:00
00:00

After receiving the pneumonia vaccine, the body generates an immune response that produces antibodies. Typically, these antibodies provide lifelong immunity. Patients with weak constitutions might need a booster shot every 3-5 years after vaccination, which generally can also lead to lifelong immunity.

Vaccinations should be administered at local, formal medical institutions. One can visit the local centers for disease control and prevention to get vaccinated. During the vaccination period, if there are any adverse reactions, they should be addressed promptly. After receiving the vaccine, it is advisable to remain at the medical facility for half an hour for observation before leaving, to prevent the occurrence of adverse reactions.

Other Voices

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
46sec home-news-image

Symptoms of pneumonia cough in children

Pneumonia in infants commonly occurs in young children, especially those under two years of age. The onset of the disease is usually rapid, starting with symptoms of upper respiratory tract infections that gradually evolve into more pronounced respiratory symptoms. The cough is frequent, initially a dry, irritating cough, that progressively worsens as the disease advances. In cases of severe pneumonia, the cough may actually lessen. During the recovery phase, the cough gradually diminishes and rattling sounds can be heard in the throat due to mucus. After the mucus is cleared, there may still be occasional bouts of irritating dry cough, which will slowly subside.

doctor image
home-news-image
Written by Wang Xiang Yu
Pulmonology
1min 24sec home-news-image

Can pneumonia vaccines prevent mycoplasma pneumonia?

Can pneumonia vaccines prevent Mycoplasma infections? First, we need to understand what pneumonia vaccines are. In our country, the most commonly used pneumonia vaccines are aimed at Streptococcus pneumoniae, which are divided into polysaccharide vaccines and conjugate vaccines. Polysaccharide vaccines are mainly suitable for individuals over two years old and include the 23-valent polysaccharide vaccine. This vaccine can prevent infections caused by twenty-three serotypes that often lead to S. pneumoniae infections, with over 90% of pneumonia caused by these twenty-three serotypes. However, the 23-valent polysaccharide vaccine does not prevent infections caused by other serotypes of S. pneumoniae. Additionally, the conjugate vaccine only prevents infections caused by either seven or thirteen serotypes. Since Mycoplasma is neither a bacterium nor a virus, it cannot be prevented by pneumonia vaccines, and currently, there is no vaccine available specifically for Mycoplasma infections.

doctor image
home-news-image
Written by Li Jiao Yan
Neonatology
59sec home-news-image

How many shots are in the pneumonia vaccine?

Currently, there are two general types of vaccines for preventing pneumococcal pneumonia. One type is the 23-valent vaccine, suitable for high-risk populations over two years old. The other type includes the 7-valent or 13-valent vaccines, which are for preventing pneumococcal infections in infants under two years old. Infants under two usually follow a "three plus one" vaccination regimen, which involves three primary immunization doses with at least one month between each dose, followed by a booster shot. Additionally, adults over two years old or other high-risk groups are advised to take the 23-valent vaccine, which requires only a single dose. However, those who are frail or have poor immune responses may need a second booster dose five years after the initial vaccination.

doctor image
home-news-image
Written by Han Shun Li
Pulmonology
45sec home-news-image

Is bronchopneumonia the same as pneumonia?

Some patients might ask if bronchopneumonia is a type of pneumonia. Undoubtedly, bronchopneumonia is a type of pneumonia, categorized anatomically. It can be classified into lobar pneumonia, bronchopneumonia, and interstitial pneumonia. During X-ray imaging, bronchopneumonia typically shows as irregular patchy shadows distributed along the lung markings, with soft and blurry edges, without signs of consolidation. It often occurs in the lower lobes of both lungs. The treatment principles for bronchopneumonia are similar to those for common pneumonia, mainly involving the use of antibiotics, cough suppressants and expectorants, fever reduction, and other symptomatic treatments.

doctor image
home-news-image
Written by Yang Feng
Pulmonology
31sec home-news-image

Are pneumonia symptoms contagious?

The main clinical symptoms of pneumonia include chills, high fever, cough, expectoration, shortness of breath, chest pain, etc. Pneumonia is a common infectious disease of the respiratory system, and it can be transmitted through the respiratory tract. However, pneumonia is not classified as a contagious disease; it is merely an infectious disease. It tends to be more prevalent during the flu season, so pneumonia is contagious, but it is not considered a contagious disease.